anemia in patients with chronic kidney disease receiving or not-receiving dialysis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged >= 18 years. 2. Consistent with the diagnosis of renal anemia. 3. Voluntary Informed Consent (ICF). 4. Baseline alanine aminotransferase or aspartate aminotransferase (AST) <= 3 x ULN, total bilirubin (TBL) <= 2 x ULN.
Exclusion criteria
Exclusion criteria: 1. Patients with severe liver disease. 2. Women who are pregnant or breastfeeding, women of reproductive age who do not use adequate contraceptives or men whose sexual partners are women of reproductive age. 3. Mental disorders can not cooperate with treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Hb level;Costs due to adverse drug events every month;Blood biochemical index; | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate of increase in HB;he proportion of patients with Hb >=10 g/dL;reticulocyte;the dose of Roxadustat used;blood pressure;Iron metabolism;Cholesterol;adverse event;Roxadustat charges every month;cost of blood tests every month; | — |
Countries
China
Contacts
Shenzhen People's Hospital